AcelRx Pharma shares sink as FDA rejects its opioid painkiller

loading...


AcelRx Pharma shares sink as FDA rejects its opioid painkiller
(Reuters) – AcelRx Pharmaceuticals Inc’s shares plunged more than 60 percent before the bell on Thursday after the U.S. Food and Drug Administration rejected the drugmaker’s opioid painkiller in its present form.


Source: Health And Fitness

Reply

Pin It on Pinterest

Shares
Share This
loading...